Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
Clinical trial NCT02988115 · COMPLETED
Trial details
- NCT number
- NCT02988115
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-16
- Primary completion
- 2018-03-16
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.